Postprandial blood glucose. American Diabetes Association.
ثبت نشده
چکیده
I ndividuals with diabetes are at increased risk of developing microvascular complications (retinopathy, nephropathy, and neuropathy) and cardiovascular disease (CVD). The Diabetes Control and Complications Trial (DCCT) (1) and U.K. Prospective Diabetes Study (UKPDS) (2) showed that treatment programs resulting in improved glycemic control, as measured by HbA1c, reduced the microvascular complications of diabetes. The effect of these treatment programs on reducing CVD was less clear. However, some epidemiological studies suggest that there may be a relationship between glycemic levels and CVD. In the management of diabetes, health care providers usually assess glycemic control with fasting plasma glucose (FPG) and premeal glucose measurements, as well as by measuring HbA1c. Therapeutic goals for HbA1c and preprandial glucose levels have been established based on the results of controlled clinical trials. Unfortunately, the majority of patients with diabetes fail to achieve their glycemic goals. Elevated postprandial glucose (PPG) concentrations may contribute to suboptimal glycemic control. Postprandial hyperglycemia is also one of the earliest abnormalities of glucose homeostasis associated with type 2 diabetes and is markedly exaggerated in diabetic patients with fasting hyperglycemia. Several therapies targeted toward lowering PPG excursions are now available and have been shown to improve glycemic control as measured by HbA1c. However, many questions remain unanswered regarding the definition of PPG and, perhaps most importantly, whether postprandial hyperglycemia has a unique role in the pathogenesis of diabetic complications and should be a specific target of therapy. To address these issues and to provide guidance to health care providers, the American Diabetes Association (ADA) convened a consensus development conference on 24–26 January 2001 in Atlanta, Georgia. A seven-member panel of experts in diabetes, endocrinology, and metabolism heard selected abstracts and presentations from invited speakers. The panel was then asked to develop a consensus position on the following questions:
منابع مشابه
دیابت و بارداری
Diabetes during pregnancy is either concurrent diabetes, diagnosed before pregnancy, or ‘gestational diabetes mellitus’ (GDM), first diagnosed in pregnancy. GDM is the commonest metabolic disorder of pregnancy, with a prevalence of one to 14 percent, depending on the reporting team. The prevalence of GDM in Tehran is 4.7%. Diabetes concurrent with pregnancy is diagnosed according to the recent...
متن کاملIs Postprandial Glucose Control Important? Is It Practical In Primary Care Settings?
There has been much debate about the effect of postprandial glucose levels on diabetes outcomes and the necessity of treating postprandial hyperglycemia in patients with type 2 diabetes. Current recommendations of the American Diabetes Association (ADA), which have been used predominantly in the United States, present goals for fasting/preprandial and bedtime glucose levels but do not define a ...
متن کاملIs Postprandial Glucose Control Important? Is It Practical In Primary Care Settings?
There has been much debate about the effect of postprandial glucose levels on diabetes outcomes and the necessity of treating postprandial hyperglycemia in patients with type 2 diabetes. Current recommendations of the American Diabetes Association (ADA), which have been used predominantly in the United States, present goals for fasting/preprandial and bedtime glucose levels but do not define a ...
متن کاملGlycemic treatment in type 1 and type 2 diabetes.
Postprandial glycemia At the meeting of the Council on Nutritional Science and Metabolism, Joan V.C. Hill (Natick, MA) introduced a session addressing the implications of postprandial blood glucose monitoring by reminding the audience that the American Diabetes Association (ADA) recommends a target HbA1c (A1C) of 7% but that the most recent National Health and Nutrition Examination Survey sugge...
متن کاملBiphasic Insulin Aspart 30: Premix Analogue for Initiating Insulin Therapy in Type 2 Diabetes
Introduction T he last two decades have seen an explosive increase in the number of people with diabetes globally due to changes in lifestyle and genetic predisposition 1,2 Patients with diabetes mellitus have an impaired capacity to regulate blood glucose. In type 1 diabetes, autoimmune destruction of pancreatic beta cells results in a diminished and rapidly absent ability to produce insulin. ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Diabetes care
دوره 24 4 شماره
صفحات -
تاریخ انتشار 2001